Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population

Volume: 16, Issue: 3, Pages: 346 - 353
Published: May 1, 2022
Abstract
Buprenorphine/naloxone is an effective medication for the treatment of opioid use disorder. Unlike methadone, which can only be dispensed in federally waived clinics and which must be combined with specific psychosocial treatment, buprenorphine can be dispensed by individual prescribers who have completed an 8-hour training program, with no requirement that patients receive concomitant psychotherapy. The objective of this study is to quantify...
Paper Details
Title
Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population
Published Date
May 1, 2022
Volume
16
Issue
3
Pages
346 - 353
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.